BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33096010)

  • 21. Osteoarthritis in 2017: Latest advances in the management of knee OA.
    McAlindon TE; Bannuru RR
    Nat Rev Rheumatol; 2018 Feb; 14(2):73-74. PubMed ID: 29323340
    [No Abstract]   [Full Text] [Related]  

  • 22. Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics.
    Oo WM; Yu SP; Daniel MS; Hunter DJ
    Expert Opin Emerg Drugs; 2018 Dec; 23(4):331-347. PubMed ID: 30415584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colchicine effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): study protocol for a randomized controlled trial.
    Leung YY; Thumboo J; Wong BS; Haaland B; Chowbay B; Chakraborty B; Tan MH; Kraus VB
    Trials; 2015 Apr; 16():200. PubMed ID: 25925674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial.
    Kingsbury SR; Tharmanathan P; Arden NK; Batley M; Birrell F; Cocks K; Doherty M; Edwards CJ; Garrood T; Grainger AJ; Green M; Hewitt C; Hughes R; Moots R; O'Neill TW; Roddy E; Scott DL; Watt FE; Torgerson DJ; Conaghan PG
    Trials; 2015 Mar; 16():77. PubMed ID: 25872649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoarthritis: Wnt inhibitor shows potential as a DMOAD.
    Onuora S
    Nat Rev Rheumatol; 2017 Nov; 13(11):634. PubMed ID: 28978991
    [No Abstract]   [Full Text] [Related]  

  • 26. New and emerging treatments for osteoarthritis management: will the dream come true with personalized medicine?
    Roubille C; Pelletier JP; Martel-Pelletier J
    Expert Opin Pharmacother; 2013 Oct; 14(15):2059-77. PubMed ID: 24044485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis.
    Langworthy MJ; Conaghan PG; Ruane JJ; Kivitz AJ; Lufkin J; Cinar A; Kelley SD
    Adv Ther; 2019 Jun; 36(6):1398-1411. PubMed ID: 30968336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does statin use have a disease modifying effect in symptomatic knee osteoarthritis? Study protocol for a randomised controlled trial.
    Wang Y; Tonkin A; Jones G; Hill C; Ding C; Wluka AE; Forbes A; Cicuttini FM
    Trials; 2015 Dec; 16():584. PubMed ID: 26700937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Considerations when designing a disease-modifying osteoarthritis drug (DMOAD) trial using radiography.
    Hellio Le Graverand MP; Clemmer RS; Brunell RM; Hayes CW; Miller CG; Vignon E
    Semin Arthritis Rheum; 2013 Aug; 43(1):1-8. PubMed ID: 23290692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Current Role of Disease-modifying Osteoarthritis Drugs.
    Rodriguez-Merchan EC
    Arch Bone Jt Surg; 2023; 11(1):11-22. PubMed ID: 36793668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OARSI/OMERACT criteria of being considered a candidate for total joint replacement in knee/hip osteoarthritis as an endpoint in clinical trials evaluating potential disease modifying osteoarthritic drugs.
    Dougados M; Hawker G; Lohmander S; Davis AM; Dieppe P; Maillefert JF; Gossec L
    J Rheumatol; 2009 Sep; 36(9):2097-9. PubMed ID: 19738220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study.
    Chevalier X; Giraudeau B; Conrozier T; Marliere J; Kiefer P; Goupille P
    J Rheumatol; 2005 Jul; 32(7):1317-23. PubMed ID: 15996071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sample Size Calculations for Detecting Disease-Modifying Osteoarthritis Drug Effects on Knee Replacement Incidence in Clinical Trials: Data From the Osteoarthritis Initiative.
    Ried JS; Flechsenhar K; Bartnik E; Crowther D; Dietrich A; Eckstein F
    Arthritis Rheumatol; 2015 Dec; 67(12):3174-83. PubMed ID: 26314914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date.
    Oo WM; Little C; Duong V; Hunter DJ
    Drug Des Devel Ther; 2021; 15():2921-2945. PubMed ID: 34262259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of intra-articular injection of tropomyosin receptor kinase A inhibitor in painful knee osteoarthritis: a randomized, double-blind and placebo-controlled study.
    Krupka E; Jiang GL; Jan C
    Osteoarthritis Cartilage; 2019 Nov; 27(11):1599-1607. PubMed ID: 31351965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel hyaluronic acid-methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models.
    Tamura T; Higuchi Y; Kitamura H; Murao N; Saitoh R; Morikawa T; Sato H
    Arthritis Res Ther; 2016 Apr; 18():79. PubMed ID: 27039182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic Review of Methylprednisolone Acetate Intra-Articular Injection in the Management of Osteoarthritis of the Knee - Part 1: Clinical Effectiveness.
    McCrum C
    Musculoskeletal Care; 2017 Mar; 15(1):79-88. PubMed ID: 27297608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synovial tissue volume: a treatment target in knee osteoarthritis (OA).
    O'Neill TW; Parkes MJ; Maricar N; Marjanovic EJ; Hodgson R; Gait AD; Cootes TF; Hutchinson CE; Felson DT
    Ann Rheum Dis; 2016 Jan; 75(1):84-90. PubMed ID: 26116548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis.
    Pelletier JP; Raynauld JP; Caron J; Mineau F; Abram F; Dorais M; Haraoui B; Choquette D; Martel-Pelletier J
    Ann Rheum Dis; 2010 Dec; 69(12):2095-101. PubMed ID: 20570834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial.
    Pers YM; Rackwitz L; Ferreira R; Pullig O; Delfour C; Barry F; Sensebe L; Casteilla L; Fleury S; Bourin P; Noël D; Canovas F; Cyteval C; Lisignoli G; Schrauth J; Haddad D; Domergue S; Noeth U; Jorgensen C;
    Stem Cells Transl Med; 2016 Jul; 5(7):847-56. PubMed ID: 27217345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.